GB9318841D0 - Composition - Google Patents

Composition

Info

Publication number
GB9318841D0
GB9318841D0 GB939318841A GB9318841A GB9318841D0 GB 9318841 D0 GB9318841 D0 GB 9318841D0 GB 939318841 A GB939318841 A GB 939318841A GB 9318841 A GB9318841 A GB 9318841A GB 9318841 D0 GB9318841 D0 GB 9318841D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939318841A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RES FOUNDATION OF NORWEGIA
Original Assignee
RES FOUNDATION OF NORWEGIA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RES FOUNDATION OF NORWEGIA filed Critical RES FOUNDATION OF NORWEGIA
Priority to GB939318841A priority Critical patent/GB9318841D0/en
Publication of GB9318841D0 publication Critical patent/GB9318841D0/en
Priority to PCT/GB1994/001951 priority patent/WO1995007077A1/en
Priority to AU75437/94A priority patent/AU7543794A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
GB939318841A 1993-09-10 1993-09-10 Composition Pending GB9318841D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB939318841A GB9318841D0 (en) 1993-09-10 1993-09-10 Composition
PCT/GB1994/001951 WO1995007077A1 (en) 1993-09-10 1994-09-08 Photochemotherapeutic compositions containing 5-aminolevulinic acid
AU75437/94A AU7543794A (en) 1993-09-10 1994-09-08 Photochemotherapeutic compositions containing 5-aminolevulinic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939318841A GB9318841D0 (en) 1993-09-10 1993-09-10 Composition

Publications (1)

Publication Number Publication Date
GB9318841D0 true GB9318841D0 (en) 1993-10-27

Family

ID=10741848

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939318841A Pending GB9318841D0 (en) 1993-09-10 1993-09-10 Composition

Country Status (3)

Country Link
AU (1) AU7543794A (en)
GB (1) GB9318841D0 (en)
WO (1) WO1995007077A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6710066B2 (en) 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
US7530461B2 (en) 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
CZ291132B6 (en) * 1995-03-10 2002-12-11 Photocure Asa Esters of 5-aminolevullinic acids and pharmaceutical preparation in which the esters are comprised
US6492420B2 (en) 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
EP1510225B1 (en) * 1995-06-05 2014-05-14 Queen's University At Kingston Photochemotherapeutic use of 5-ALA in the treatment of acne
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2759289B1 (en) * 1997-02-12 1999-04-23 Chu Nantes NEW APPLICATION OF A DEPIGMENTANT
JPH1112197A (en) * 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk Malignant tumor diagnostic agent and therapeutic agent
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
DE19744811C2 (en) * 1997-10-02 1999-11-18 Medac Klinische Spezialpraep Use of delta-aminolevulinic acid for the production of a topical medicament for the integral diagnosis and / or therapy of tumors in hollow organs
ES2244169T3 (en) * 1998-02-09 2005-12-01 Bracco International B.V. ADDRESSED SUPPLY OF BIOLOGICALLY ACTIVE MEDIA.
DE19827417B4 (en) 1998-06-19 2004-10-28 Hahn, Rainer, Dr.Med.Dent. Material for different modification of the optical properties of different cells
SE512224C2 (en) 1998-06-26 2000-02-14 Medeikonos Ab Device for application of delta aminolevulinic acid (ALA) to the skin in cancer detection and to protect the skin area with ALA applied to lice
US6183773B1 (en) 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
GB9912998D0 (en) * 1999-06-04 1999-08-04 Sls Biophile Limited Depilation
SE9903057L (en) * 1999-08-27 2001-02-28 Medeikonos Ab ILLUMINATOR
JP3970492B2 (en) * 1999-12-14 2007-09-05 コスモ石油株式会社 Peeling composition
DE10034673C1 (en) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermal application system for aminolevulinic acid and its use
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
CA2422865C (en) 2000-08-16 2012-10-16 The General Hospital Corporation D/B/A Massachusetts General Hospital Aminolevulinic acid photodynamic therapy for treating sebaceous gland disorders
EP2248536A3 (en) 2000-12-14 2010-12-08 The General Hospital Corporation doing business as Massachusetts General Hospital Topical Aminolevulinic acid-photodynamic therapy for acne vulgaris
DK1339862T3 (en) 2000-11-29 2014-02-17 Pci Biotech As PHOTO CHEMICAL INTERNALISATION VIRUS-MEDIATED MOLECULAR-DELIVERY INTO cytosol
AU2085302A (en) 2000-11-29 2002-06-11 Norwegian Radium Hospital Res Photochemical internalization for delivery of molecules into the cytosol
RU2187347C1 (en) 2001-01-12 2002-08-20 Государственный научный центр Российской Федерации "НИОПИК" Method and applicator for photodynamic therapy
ITMI20010685A1 (en) * 2001-03-30 2002-09-30 Biochimici Psn S P A DELTA-AMINOLEVULINIC ACID FOR MEDICAL AND COSMETIC USE
AU2002340659B2 (en) * 2001-11-09 2008-04-10 Qlt Inc. Photodynamic therapy for the treatment of hair loss
US7264629B2 (en) 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
DE10202487A1 (en) 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermal application system for aminolevulinic acid derivatives
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
US8585707B2 (en) 2006-06-07 2013-11-19 Gary S. Rogers Continuous low irradiance photodynamic therapy method
ES2454974T3 (en) 2007-06-27 2014-04-14 The General Hospital Corporation Apparatus for optical inhibition of photodynamic therapy
WO2009066294A1 (en) * 2007-11-20 2009-05-28 Hy Biopharma Inc. Device and method for photodynamic therapy
GB0823472D0 (en) * 2008-12-23 2009-01-28 Photocure Asa Product
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1598944A1 (en) * 1987-12-29 1990-10-15 Отраслевая Научно-Исследовательская Лаборатория Дистанционной Диагностики Института Общей Физики - Института Геохимии И Аналитической Химии Ан Ссср При Наманганском Государственном Педагогическом Институте Им.Хамзы Composition for defoliation of cotton
NZ231658A (en) * 1988-12-12 1992-05-26 Fmc Corp Inhibitors of protoporphyrinogen oxidase and compositions for killing tumour cells
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
JPH0757196B2 (en) * 1989-11-27 1995-06-21 株式会社コスモ総合研究所 Method for producing delta-aminolevulinic acid and herbicide

Also Published As

Publication number Publication date
AU7543794A (en) 1995-03-27
WO1995007077A1 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
GB9318841D0 (en) Composition
HK1012284A1 (en) Novel composition
IL110665A0 (en) Erection-inducing compositions
ZA942052B (en) Tricritical point composition
GB9302130D0 (en) Cleasing composition
GB9318641D0 (en) Compositions
GB9313274D0 (en) Composition
GB9310700D0 (en) Novel composition
GB9323313D0 (en) Clenasing compositions
GB9304823D0 (en) Cable-making compositions
GB2281914B (en) Composition
GB9310756D0 (en) Compositions
ZA946967B (en) Lyophillisate composition
ZA949377B (en) Novel composition
GB9301289D0 (en) Novel composition
GB2282385B (en) Composition
GB9313759D0 (en) Cementiferous compositions
GB9320370D0 (en) Frit-containing composition
GB9320598D0 (en) Composition
GB9321876D0 (en) Novel composition
GB9317222D0 (en) Composition
GB9317063D0 (en) Composition
SG48328A1 (en) Composition
GB9319818D0 (en) Composition
GB9318548D0 (en) Composition